Global Interventional Cardiology Devices Market is estimated to witness a CAGR of 2 to 3% by 2026 - Rising Incidence of Diabetes & Associated Increased Risk of Coronary Heart Diseases

Interventional cardiology is a branch of cardiology which utilizes the nonsurgical, catheter-based treatments for structural heart diseases. It utilizes medical devices such as catheters & sheaths, guidewires, balloons, stents, vascular closure devices, atherectomy devices, intravascular ultrasound (IVUS), and other devices to repair narrowed arteries, damaged or weakened blood vessels, heart valve disorders, and congenital heart diseases.

Growing prevalence of cardiovascular diseases & hypertension, a higher degree of unmet clinical needs, and an increasing affluence are creating ample growth opportunities for the interventional cardiology devices market in the Asia-Pacific region. The growth of the interventional cardiology devices market in the APAC region is likely to be driven by China and India. Considering the healthy growth prospects of the interventional cardiology devices market in the APAC region, leading companies have expanded their stronghold in these regions.

For instance,

• In March 2022, Boston Scientific expanded its footprint in India with its second R&D Center. The new R&D Center addresses the needs of the medical patients in India, Asia-Pacific, and all across the world. It also provides expertise to all of the company's diverse therapy areas, namely interventional cardiology, peripheral interventions, cardiac rhythm management, endoscopy, neuromodulation, urology, and pelvic health.

"China is one of the leading markets for cardiovascular diseases. The demand from patients to be treated as well as doctors to get trained is vast. This is why interventional cardiology device manufacturers are investing in the Chinese market."-Director, Leading Stent Manufacturer, United States

Technological Innovations are driving the growth of the Interventional Cardiology Devices Market

The interventional cardiology devices market is a technology-driven market and is marked by product advancements. For instance,

• In May, 2022, Medtronic received US FDA approval for the Onyx Frontier™ drug-eluting stent (DES). The Onyx Frontier DES is used for the treatment of patients with coronary artery disease (CAD). It offers an innovative delivery system and builds upon the acute performance and clinical data from the Resolute Onyx™ drug-eluting stent.
• In April 2022, Translumina launched VIVO ISAR, its latest generation dual drug polymer-free coated stent (DDCS), in various international markets including Europe.

Growth Strategies Adopted by Leading Market Players to Establish Their Foothold in the Interventional Cardiology Devices Market

The global interventional cardiology devices market is marked by the presence of both established and emerging players. Players operating in this market have adopted both organic and inorganic growth strategies such as acquisitions, and new product launches to garner a higher market share.

For instance,
• In April 2022, Transit Scientific announced the FDA clearance of its XO Cross® Support Catheter Platform to include coronary use. The platform is indicated to guide and support a guidewire during access of the peripheral or coronary vasculature, allow for wire exchanges, and provide a conduit for delivery of saline solutions or diagnostic contrast agents.
• In April 2022, Boston Scientific announced the close of its acquisition of Baylis Medical Company Inc., a company that offers advanced transseptal access solutions as well as guidewires, sheaths and dilators used to support catheter-based left-heart procedures.

Competitive Landscape Analysis: Interventional Cardiology Devices Market

The interventional cardiology devices market is marked by the presence of established market players such as Medtronic, Boston Scientific, Abbott, Medinol, Biotronik, SMT, Terumo, Lepu Medical, Microport, among others.

Get Detailed Insights on Interventional Cardiology Devices Market with a Sample Report PDF @ https://meditechinsights.com/interventional-cardiology-devices-market/

Ruta Halde
Associate, Medi-Tech Insights
+32 498 86 80 79
info@meditechinsights.com
https://meditechinsights.com/

Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have successfully completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services.

This release was published on openPR.